Psychiatry and Neurology, Neurology · Guaynabo, PR
NPI
1720029317
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Centro Internacional de Mercadeo, Suite 306
Guaynabo, PR, 00969
Phone (787) 793-7984
Medicare paid, 2024
$35K
5,302 services
Medicare patients, 2024
55
Average age 70
Drug cost, 2024
$19.6M
5,780 prescriptions
Company payments, 2025
$273K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angel R Chinea Sr. was code J0585 (injection, onabotulinumtoxina, 1 unit), 5,200 times for 12 patients. In total Angel R Chinea Sr. billed 5,302 services in 7 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 5,200 | 12 | $4.90 | $25K |
| 99214 Office E&M - Established | Office | 56 | 37 | $83.21 | $4,660 |
By year: 2022 $44K for 6,889 services; 2023 $45K for 7,021 services; 2024 $35K for 5,302 services.
Medicare prescription drug claims, 2024
In 2024, the drug Angel R Chinea Sr. prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 755 prescriptions and refills. In total Angel R Chinea Sr. wrote 5,780 Medicare prescriptions that cost $19.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalfampridine Er Dalfampridine | 755 | 763 | 79 | $91K |
| Kesimpta Pen Ofatumumab | 530 | 530 | 54 | $4.8M |
| Baclofen Generic | 522 | 546 | 133 | $10K |
| Gabapentin Generic | 445 | 506 | 108 | $6,903 |
| Aubagio Teriflunomide | 209 | 209 | 21 | $1.9M |
| Vumerity Diroximel Fumarate | 169 | 177 | 19 | $1.5M |
| Clonazepam Generic | 147 | 147 | 35 | $1,857 |
| Teriflunomide Generic | 138 | 138 | 17 | $64K |
| Famotidine Generic | 133 | 143 | 69 | $392 |
| Emgality Pen Galcanezumab-Gnlm | 115 | 126 | 18 | $89K |
| Tizanidine Hcl Generic | 112 | 116 | 33 | $4,592 |
| Ampyra Dalfampridine | 111 | 111 | Under 11 | $479K |
| Gilenya Fingolimod Hcl | 110 | 110 | 18 | $1.2M |
| Dimethyl Fumarate Generic | 97 | 97 | 14 | $37K |
| Mavenclad Cladribine | 92 | 94 | 50 | $6.3M |
Brand drugs: - claims; generic drugs: 3,913 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angel R Chinea Sr. $273K ($266K in general payments such as food, travel and fees and $6,685 for research) from 17 companies. The largest payer was EMD Serono, Inc. with $142K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 70 | $142K |
| Biogen, Inc. BIIB | 47 | $42K |
| Abbvie Inc. ABBV | 21 | $28K |
| TG Therapeutics, Inc. TGTX | 28 | $22K |
| Genentech USA, Inc. ROG.SW | 24 | $17K |
| Novartis Pharmaceuticals Corporation NVS | 35 | $9,063 |
| Amgen Inc. AMGN | 10 | $7,366 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $4,254 |
| ANI Pharmaceuticals, Inc. ANIP | 15 | $373 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $132 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.